Cheng CY, Hao WR, Cheng TH. Unveiling significant risk factors for intensive care unit-acquired weakness: Advancing preventive care. World J Clin Cases 2024; 12(18): 3288-3290 [PMID: 38983419 DOI: 10.12998/wjcc.v12.i18.3288]
Reader's ID:
08058032
Submitted on:
June 24, 2024, 10:13
Reader Expertise:
Reader’s expertise on the topic of the manuscript
Conflicts-of-Interest Statement:
Does the reader have a conflict of interest?
Reader Comment Standards for Published Articles:
1 Title
Does the title reflect the main subject/hypothesis of the manuscript?
2 Abstract
Does the abstract summarize and reflect the work described in the manuscript?
3 Key Words
Do the key words reflect the focus of the manuscript?
4 Background
Does the manuscript adequately describe the background, present status and significance of the study?
5 Methods
Does the manuscript describe methods (e.g., experiments, data analysis, surveys, and clinical trials, etc.) in adequate detail?
6 Results
Are the research objectives achieved by the experiments used in this study?
Has the study made meaningful contributions towards research progress in this field?
7 Discussion
Does the manuscript interpret the findings adequately and appropriately, highlighting the key points concisely, clearly and logically?
Are the findings and their applicability/relevance to the literature stated in a clear and definite manner?
Is the Discussion accurate and does it discuss the paper’s scientific significance and/or relevance to clinical practice sufficiently?
8 Illustrations and Tables
Are the figures, diagrams and tables sufficient, good quality and appropriately illustrative of the paper contents?
Do figures require labeling with arrows, asterisks, etc., or better legends?
9 Biostatistics
Does the manuscript meet the requirements of biostatistics?
10 Units
Does the manuscript meet the requirements of use of SI units?
11 References
Does the manuscript appropriately cite the latest, important and authoritative references in the Introduction and Discussion sections?
Does the author self-cite, omit, incorrectly cite and/or over-cite references?
12 Quality of manuscript organization and presentation
Is the manuscript concisely and coherently organized and presented?
Are the style, language and grammar accurate and appropriate?
13 Ethics statements
For all manuscripts involving human studies and/or animal experiments, author(s) must submit the related formal ethics documents that were reviewed and approved by their local ethical review committee. Did the manuscript meet the requirements of ethics?
Scientific Quality:
The overall quality of the manuscript, based on the above-listed criteria, should be evaluated and classified according to the following five categories
Language Quality:
Language quality (style, grammar, and spelling) should be evaluated and classified according to the following five categories.
Reader Comments:
Clear cell sarcoma of the pancreas, whether primary or metastatic, represents a rare and challenging subset of cancers. Primary pancreatic sarcomas, such as clear cell sarcoma, are notably uncommon compared to the predominant epithelial adenocarcinomas and neurogenic malignancies of the pancreas. They require careful differentiation from gastrointestinal and retroperitoneal sarcomas that may involve the pancreas secondarily.
The incidence of clear cell sarcoma across various databases ranges from 0.01 to 0.29 cases per 100,000 individuals annually, underscoring its rarity. This rarity poses diagnostic and therapeutic dilemmas, necessitating a nuanced approach in clinical practice.
Metastatic clear cell sarcoma of the pancreas, originating typically from distant sites like soft tissues or bones, further complicates management strategies. Treatment involves tailored systemic therapies aimed at the tumor's molecular profile, reflecting advancements in precision medicine.
In conclusion, clear cell sarcoma of the pancreas exemplifies a rare cancer phenotype, demanding heightened awareness among clinicians and researchers. Enhanced understanding of its distinctive characteristics is pivotal for accurate diagnosis and effective treatment strategies, ensuring optimal patient outcomes in this challenging oncological landscape.
Reply from the Editorial Office:
First, thank you very much for your professional comments on the article published in World Journal of Clinical Cases.
Second, we read your comments with great interest. You are welcome to format your valuable comments into a Letter to the Editor and submit it online to World Journal of Clinical Cases at https://www.f6publishing.com. There are no restrictions on the number of words, figures (color, B/W) or authors for a Letter to the Editor. In addition, the article processing charge will be exempted for this Letter to the Editor. As with all articles published by the Baishideng Publishing Group, the Letter to the Editor will be published online after completing peer review. The guidelines for a Letter to the Editor can be found at: https://www.wjgnet.com/bpg/GerInfo/219.
Finally, we look forward to receiving your high-quality Letter to the Editor, which will promote academic communication and lead the development of this discipline.
Author's Reply:
Replied on June 26, 2024, 18:04
We appreciate the insightful comments and detailed observations regarding the rare and challenging nature of clear cell sarcoma of the pancreas. The rarity and complexity of this subset of cancers indeed present significant diagnostic and therapeutic dilemmas. Your emphasis on the necessity for careful differentiation from other sarcomas and the importance of a tailored, molecular profile-based treatment approach aligns well with the current trends in precision medicine.
In the context of our editorial on ICU-acquired weakness (ICU-AW), it is essential to underscore the broader implications of recognizing and managing rare conditions such as clear cell sarcoma. The principles of early identification, precise diagnosis, and individualized treatment are equally critical in preventing and mitigating ICU-AW. As ICU-AW often complicates the recovery of critically ill patients, a nuanced understanding of its risk factors, akin to the detailed characterization required for rare cancers, is paramount.
Your comments also highlight the need for continuous education and heightened awareness among clinicians and researchers, which is crucial for both rare cancer phenotypes and ICU-acquired conditions. Our aim with the editorial was to advance preventive care strategies for ICU-AW, and your feedback reinforces the importance of a comprehensive, informed approach in clinical practice.
We thank you for your valuable contribution to the discourse and look forward to further discussions that enhance patient outcomes through collaborative efforts and shared knowledge.
Sincerely,
Tzu-Hurng Cheng